E Fund Management (HK)’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$147K Buy
2,183
+882
+68% +$58.8K 0.05% 169
2026
Q1
$81.7K Buy
1,301
+109
+9% +$7.59K 0.04% 165
2025
Q4
$86.5K Buy
1,192
+913
+327% +$59K 0.03% 165
2025
Q3
$18.8K Buy
279
+213
+323% +$16.9K 0.01% 143
2025
Q2
$5.76K Hold
66
0.01% 141
2025
Q1
$5K Sell
66
-181
-73% -$14.8K ﹤0.01% 151
2024
Q4
$19K Buy
247
+244
+8,133% +$18.1K 0.02% 89
2024
Q3
$0 Hold
3
﹤0.01% 140
2024
Q2
$0 Buy
+3
New +$379 ﹤0.01% 120

Other funds holding DXCM

E Fund Management (HK)'s DXCM Position: Q2 2026 in Review

E Fund Management (HK) increased its DexCom (DXCM) stake by 68% in Q2 2026, buying an estimated $58.8K and bringing the position to 2,183 shares worth $147K. The position accounts for 0.05% of the portfolio, ranked #169.

E Fund Management (HK) first reported a position in DXCM in Q2 2024 and has held it in 9 quarters since. 174 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • E Fund Management (HK) held 2,183 shares of DexCom worth $147K as of Q2 2026.
  • E Fund Management (HK) bought 882 DexCom shares in Q2 2026, an estimated $58.8K.
  • DexCom made up 0.05% of E Fund Management (HK)'s portfolio in Q2 2026, its #169 holding.
  • E Fund Management (HK) first reported a position in DexCom in Q2 2024 and has held it in 9 quarters since.
  • 174 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on E Fund Management (HK)'s 13F filing for Q2 2026, filed 22 Jul 2026.